Pradhan, Nirparaj <br/><br/>
Curcumin nanoparticles inhibit corneal neovascularization.  [electronic resource] 

 -  Journal of molecular medicine (Berlin, Germany)  Oct 2015 
 - 1095-106 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1440 
<br/><br/><label>Standard No.: </label>10.1007/s00109-015-1277-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Aorta, Thoracic--drug effects<br/>Cells, Cultured<br/>Cornea--drug effects<br/>Corneal Keratocytes--drug effects<br/>Corneal Neovascularization--drug therapy<br/>Curcumin--administration & dosage<br/>Drug Carriers--administration & dosage<br/>Female<br/>I-kappa B Proteins--metabolism<br/>Interleukin-1beta--genetics<br/>Lipopolysaccharides<br/>Male<br/>Mice<br/>NF-KappaB Inhibitor alpha<br/>NF-kappa B--metabolism<br/>Nanoparticles--administration & dosage<br/>Polyesters--chemistry<br/>Polyethylene Glycols--chemistry<br/>Rats, Sprague-Dawley<br/>Tumor Necrosis Factor-alpha--genetics<br/>Vascular Endothelial Growth Factor A--genetics